发明授权
- 专利标题： Dihydropyrrolopyridine inhibitors of ROR-gamma
- 专利标题（中）： ROR-γ的二氢吡咯并吡啶抑制剂
-
申请号： US14609798申请日： 2015-01-30
-
公开(公告)号： US09266886B2公开(公告)日： 2016-02-23
- 发明人: Stephen D. Lotesta , Andrew Marcus , Jing Yuan
- 申请人： Vitae Pharmaceuticals, Inc.
- 申请人地址： US PA Fort Washington
- 专利权人： Vitae Pharmaceuticals, Inc.
- 当前专利权人： Vitae Pharmaceuticals, Inc.
- 当前专利权人地址： US PA Fort Washington
- 代理机构： McCarter & English LLP
- 代理商 Steven G. Davis; Michael J. DeGrazia
- 主分类号： C07D401/02
- IPC分类号： C07D401/02 ; C07D401/10 ; A61K31/437 ; A61K31/4353 ; C07D471/04
摘要：
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
公开/授权文献
- US20150218160A1 DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA 公开/授权日：2015-08-06
信息查询
